NOV 2014 ARTICLE LIST >>
PharmaTutor (November- 2014)
ISSN: 2347 - 7881
(Volume 2, Issue 11)
Received On: 10/09/2014; Accepted On: 18/09/2014; Published On: 01/11/2014
AUTHORS: Farhana V. Buchiya*, Vineet Jain, Hasumati Raj
Shree Dhanvantary Pharmacy College,
Kim, Surat, Gujarat
buchiyafarhana22@gmail.com
ABSTRACT:
Cilnidipine is act as a dual blocker by blocking L- type of calcium channel present in vascular smooth muscles and N- type of calcium channel present in sympathetic nerve terminal that supply blood vessels. Cilnidipine used in treatment of mostly in hypertension and various cardiovascular diseases except in Angina. Cilnidipine used alone or in combination. This review covers most recent analytical methods such as various spectroscopic methods, chromatographic methods and other methods for determination of cilnidipine in various pharmaceutical dosage forms and biological matrix were reported.
How to cite this article: FV Buchiya, V Jain, R Hasumati; A Review: Analytical Methods for Determination of Cilnidipine in Biological Fluid and Pharmaceutical Dosage Forms; PharmaTutor; 2014; 2(11); 22-29
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Kokilambigai KS and Lakshmi KS, “Analytical Methodologies for Determination of Cilnidipine: An Overview”. International Journal of Pharmacy and Pharmaceutical Science.2014; 6.
2. Drug Profile Available from: Abchem biomedicals Cilnidipine ab141038, product datasheet
3. Drug Profile Available from: drugs.com/
4. Drug Profile Available from: productblock/Cilnidipine(CAS132203-704)/
5. Drug Profile Available from: mims.com/
6. Mechanism of action available from: faculty.ksu.edu.sa/.../calcium_channel_blockers_reserch.do./
7. Sarat K and Ramesh G. “The fourth-generation Calcium channel blocker Cilnidipine”. Indian Heart Journal. Dec 2013; 65: 691–695.
8. medicineindia.org/pharmacology-for-generic/2958/cilnidipine
9. medguideindia.com/
10. Mohd IS and Medidi S, “Simultaneous estimation of Telmisartan and Cilnidipine in bulk and in tablet formulation using RP-HPLC”. An International Journal of Advances in Pharmaceutical Sciences. May-June 2014; 5: 2142-2148.
11. Prajakta P and Santosh VG, “Simultaneous RP-HPLC estimation of Cilnidipine and telmisartan in combined tablet dosage form”. Pelagia Research Library Der Chemica Sinica. 2013; 4: 6-10.
12. Amit SM, Manjusha ND and Sanjay DS, “Developement and validation of analytical method for simultaneous estimation of Cilnidipine and olmesartan medoxomil in bulk and tablet dosage form by RP-HPLC”. International Journal of Pharmacy and Pharmaceutical Science. 2014; 6.
13. Tushar KK, Darshil BS and Dr. Dilip GM, “Development and validation of q-absorbance ratio Spectrophotometric method for simultaneous estimation of Cilnidipine and metoprolol succinate in bulk and combined dosage form”. International Journal of Pharmacy and Pharmaceutical Sciences. 2014; 6.
14. Vaghela S, Jagdish K, Pinak P and Nehal S, “Devlopment and validation of high performance thin layer chromatographic Method for Cilnidipine and metoprolol succinate in their combined Pharmaceutical dosage form”. International Journal of Research in Pharmaceutical and Nano Sciences. 2014; 3:61 - 72.
15. Mohammed MS, “Spectrophotometric Method for the Estimation of Cilnidipine in Bulk and Pharmaceutical Dosage forms.” Oriental journal of chemistry. 2013; 29:131-134.
16. Pankaj PC and Bhalerao V, “Method validation for spectrophotometric estimation of Cilnidipin”. International Journal of Pharmacy and Pharmaceutical Sciences. 2012, 4.
17. Haripriya M and Neethu A, “Development and validation of UV spectrophotometric method for the simultaneous estimation of Cilnidipine and telmisartan in tablet dosage form utilising simultaneous equation and absorbance ratio method”. Research article pharmaceutical sciences. Jan-Mar 2013;3:343-348
18. Shahin V and Falgun M, “Dual Wavelength Spectrophotometric Method for Estimation of Cilnidipine and Telmisartan in Their Combined Dosage Form”. Research and Reviews: Journal of Pharmaceutical Analysis. April - June 2014; 3.
19. Isha JS and Hiral JP, “Development and Validation of Dual Wavelength UV Spectrophotometric Method for simultaneous estimation of Cilnidipine and Olmesartan Medoxomil in Tablet dosage form”. Indian Journal of Pharmaceutical and Biological Research. 2014; 2:76-81.
20. Tushar KK, Darshil BS and Dr. Dilip GM, “Development and validation of q-absorbance ratio Spectrophotometric method for simultaneous estimation of Cilnidipine and metoprolol succinate in bulk and combined dosage form”. International Journal of Pharmacy and Pharmaceutical Sciences. 2014; 6.
21. Mohammed SM and Nagaraj MY,” Development and validation of a Rapid Stability Indicating chromatographic determination of Cilnidipine in Bulk and Dosage form”. Research Journal of Pharmacy and Technology. 2013; 6: 296-299.
22. Reema HR and Hitendra SJ, “Stability Indicating Simultaneous Validation of Telmisartan and Cilnidipine with Forced Degradation Behaviour Study by RP-HPLC in Tablet Dosage Form”. Research Article. 2013: 6.
23. Kyeong R and Yoon JC, “Quantification of Cilnidipine human plasma by liquid chromatography- mass spectrometry”. Journal of liquid chromatography & related technologies.35: 308-320.
24. Heon WF and Ji Hyung S, “Development of a liquid chromatography/negative-ion electroscopy tandem mass spectrometry assay for the determination of Cilnidipine in human plasma and its application to a bioequivalence study”. Journal of Chromatography B. February 2008; 862: 246–251.
.png)
